Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Luttmann

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Pharmacology Research & Perspectives|May 9, 2018
Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissuesSharath S Hegde, M Teresa Pulido-Rios, Mark A Luttmann, et al.
Archives of Neurology|July 13, 2000
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trialM Vorgerd, T Grehl, M Jager, et al.
British Journal of Pharmacology|October 26, 2011
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptorsR J Slack, L J Russell, D A Hall, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in miceD E Griswold, S A Douglas, L D Martin, et al.
Patient Preference and Adherence|May 5, 2025
Disease Impact and Perception of Biologics in Adults with Type 2 Inflammation Respiratory Disease: International Survey ResultsRuth Tal-Singer, Kristen S Willard, Mark A Luttmann, et al.
Molecular Pharmacology|September 25, 1999
Endothelin B receptor modulates inflammatory pain and cutaneous inflammationD E Griswold, S A Douglas, L D Martin, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|October 17, 2007
[Radiological diagnosis of lumbar prolaps with quantitative and morphological criteria]O Linhardt, A K Bergmann, U Bolm-Audorff, et al.
European Journal of Pharmacology|February 28, 2001
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptorH M Sarau, J A Feild, R S Ames, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Brent McCleland, Sonia Thomas, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Pharmacology Research & Perspectives|May 9, 2018
Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissuesSharath S Hegde, M Teresa Pulido-Rios, Mark A Luttmann, et al.
Archives of Neurology|July 13, 2000
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trialM Vorgerd, T Grehl, M Jager, et al.
British Journal of Pharmacology|October 26, 2011
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptorsR J Slack, L J Russell, D A Hall, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in miceD E Griswold, S A Douglas, L D Martin, et al.
Patient Preference and Adherence|May 5, 2025
Disease Impact and Perception of Biologics in Adults with Type 2 Inflammation Respiratory Disease: International Survey ResultsRuth Tal-Singer, Kristen S Willard, Mark A Luttmann, et al.
Molecular Pharmacology|September 25, 1999
Endothelin B receptor modulates inflammatory pain and cutaneous inflammationD E Griswold, S A Douglas, L D Martin, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|October 17, 2007
[Radiological diagnosis of lumbar prolaps with quantitative and morphological criteria]O Linhardt, A K Bergmann, U Bolm-Audorff, et al.
European Journal of Pharmacology|February 28, 2001
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptorH M Sarau, J A Feild, R S Ames, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Brent McCleland, Sonia Thomas, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Pageof 6